Can we assess the efficacy of therapy in neurocardiogenic syncope?
- PMID: 11216979
- DOI: 10.1016/s0735-1097(00)01150-5
Can we assess the efficacy of therapy in neurocardiogenic syncope?
Comment on
-
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.J Am Coll Cardiol. 2001 Feb;37(2):554-9. doi: 10.1016/s0735-1097(00)01155-4. J Am Coll Cardiol. 2001. PMID: 11216978 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
